Group 1 - The cancer prevention and treatment situation in China remains severe, with 4.82 million new cancer cases and 2.57 million deaths reported in 2022, indicating a diagnosis every minute and a death every 15 seconds [1] - The top five cancers in terms of new cases are lung cancer, colorectal cancer, thyroid cancer, liver cancer, and stomach cancer, which together account for 57.42% of new cases, highlighting key areas for cancer prevention [1] - Early detection significantly improves cure rates for cancers, particularly colorectal cancer, where the five-year survival rate is 91.8% if detected early, but drops to 10.8% if treatment is delayed [1] Group 2 - Nohui Health's Changweiqing is a non-invasive colorectal cancer screening product that requires only a stool sample, utilizing triple detection technology with a negative predictive value of 99.6% [3] - All commercialized products from Nohui Health are supported by extensive clinical data, ensuring their professionalism, compliance, reliability, and high recognition [3] - Changweiqing is the only product included in all national colorectal cancer screening and treatment guidelines in China, underscoring its significance in the market [3]
关注无痛肠癌早筛 诺辉健康(06606)常卫清守护家人的“肠”寿之道